Nutritional Growth Solutions (ASX:NGS) announced that, by mutual agreement, Stephen J. Turner will step down as CEO and Managing Director, effective Jan. 30, 2026.
Turner will remain with the company until the departure date to ensure a smooth transition, including the handover of company information, systems, and operational responsibilities.
The company also confirmed that Andrew Grover, a current non-executive director, will assume the role of Interim CEO until a permanent appointment is made.
Grover brings more than 30 years of experience founding, scaling, and exiting businesses across technology, healthcare, and professional services.
He is currently executive chair of Echo IQ (ASX:EIQ), where he has overseen substantial market growth.
Renowned for driving strategic rebuilds, building high-performance leadership teams, and delivering sustained commercial growth, Grover will not receive additional remuneration for serving in the interim role.